NCT01401933View on ClinicalTrials.gov

Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Advanced Solid Tumors
Interventions
DRUG

Linifanib

QD on Days 1 and 13

DRUG

Rifampin

QD on Days 5-16

Trial Locations (2)

53792

Site Reference ID/Investigator# 49952, Madison

85724-5024

Site Reference ID/Investigator# 49953, Tucson

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY